Developer CHP Group has accused real estate agency Maison Global of having a conflict of interest while selling apartments in Sydney Olympic Park’s latest high-rise the Boomerang building due to a separate arrangement with a different developer.
Pitcher Partners has lost its appeal of a decision that refused to stay a lawsuit over the accounting firm’s alleged involvement in race car driver Max Twigg’s misappropriation of $127 million from his family.
The legal sector has welcomed NSW Supreme Court Justice Robert Beech-Jones’ elevation to the highest court in Australia, with former colleagues noting his legal acumen and generosity.
Dominique Grubisa has come up short in her bid to have the Australian Competition and Consumer Commission file formal pleadings in its case alleging she misled students enrolled in her real estate investing and wealth management courses.
The legal community has welcomed the appointment of Justice Stephen Gageler to be the 14th chief justice of the High Court, praising the judge for his “deep humanity” and unmatchable expertise in constitutional law.
A Star Entertainment joint venture has been hit with a lawsuit by the Queensland arm of Multiplex Constructions over alleged costs overruns in the construction for a multi-billion-dollar resort in Brisbane.
Qantas faces a class action on behalf of hundreds of thousands of customers who allegedly never received refunds after flights were cancelled during the COVID-19 pandemic.
A shareholder class action that was filed in the wake of the banking royal commission over AMP’s fees-for-no-service practices has settled for $110 million.
A Deloitte partner has brought legal action against a Sydney builder over variations to a $1.5 million contract to renovate his house in the waterfront suburb of Balmain, claiming the increases were meant as “cash support” for the construction business.
Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.